Clinical Trial Update: Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized controlled trial update assessing rifaximin for reducing complications in decompensated cirrhosis is reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Cirrhosis | Phase 4 | Status: UNKNOWN